The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 04, 2025

Filed:

Jun. 10, 2021
Applicant:

Amgen Inc., Thousand Oaks, CA (US);

Inventors:

Benjamin C Milgram, Cambridge, MA (US);

Isaac E Marx, Arlington, MA (US);

Haoxuan Wang, Somerville, MA (US);

Alan H Cherney, Somerville, MA (US);

Assignee:

AMGEN INC., Thousand Oaks, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 413/12 (2006.01); A61P 25/04 (2006.01); C07D 215/36 (2006.01); C07D 401/12 (2006.01);
U.S. Cl.
CPC ...
C07D 413/12 (2013.01); A61P 25/04 (2018.01); C07D 215/36 (2013.01); C07D 401/12 (2013.01);
Abstract

The present invention provides a cyclobutyl dihydroquinoline sulfonamide compound of Formula (I), an enantiomer, diastereoisomer, atropisomer thereof, a mixture thereof, or a pharmaceutically acceptable salt thereof, that inhibits voltage-gated sodium channels, in particular Nav1.7. The compounds are useful for the treatment of diseases associated with the activity of sodium channels such as pain disorders, cough, and itch. Also provided are pharmaceutical compositions containing the compounds of the present invention. Also further provided is an atropi-selective preparation of said compounds of Formula (I), and intermediate thereof.


Find Patent Forward Citations

Loading…